Articles > Health magazines > Medical magazines > Clinical Trials Week articles > April 2009

Article: NanoTox[R] Continues to Attract Dynamic Leaders with Addition of La Jolla Capital Partners CEO, C. Richard Piazza, to Board of Directors.

Article from:
Clinical Trials Week
Article date:
April 13, 2009
Copyright

nanoTox, the first company to provide complete risk analysis and profiling exclusively for nanoparticles, announced that C. Richard Piazza has joined the board of directors of its parent company Nano Risk Assessment, Inc. Mr. Piazza is founder and CEO of private equity firm La Jolla Capital Partners, LLC and an established leader in the biotechnology and pharmaceutical industries.

"We look forward to gaining from Mr. Piazza's vast knowledge," said Harry Bushong, president of nanoTox. "With his decades of experience leading prominent biotech and pharmaceutical companies to profitability, Mr. Piazza's insights and direction will be instrumental in assuring the ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Private investment firm Leucadia Capital Partners ...
San Diego Business Journal;  May 14, 2007 ;     700+ words ... ... Pacific Corporate Group announced the launch of Leucadia Capital Partners LLC last week. Led by Chief Executive Officer Monte Brem ... same market as Pacific Corporate Group. Both are based in La Jolla. Brem said private equity investors tend to work with endowments ...

Article: Small change: Pacific Corporate Group, a La ...
San Diego Business Journal;  May 30, 2005 ;     700+ words ...Small Change: Pacific Corporate Group, a La Jolla-based investment management and advisory firm, reorganized into two divisions, Asset Management and Capital Partners. Asset Management oversees more than $20 billion in private equity commitments ...

Article: Biotech stock falls after poor test results: La ...
San Diego Business Journal;  February 24, 2003 ;     700+ words ... ... Administration approval for Riquent. La Jolla, meanwhile, said it plans ... before revising his opinion. La Jolla executives offered some explanations ... Los Angeles-based Roth Capital Partners Inc. said it downgraded La Jolla's stock from "buy" to ...

Article: La Jolla shores site of proposed luxury condominium ...
San Diego Business Journal;  November 11, 2002 ;     700+ words ... ... Jolla Shores Inn and the Inn at La Jolla. CLB purchased the property in ... a $100 million project named La Jolla Shores. Stephen M. Chiles and Nicholas Arthur of La Jolla Capital Partners represented CLB in the purchase ...

Article: LA JOLLA RAISING $35.3M PRIVATELY TO FUND ...
BIOWORLD Today;  February 7, 2001 ;     700+ words ...La Jolla Pharmaceutical Co. said ... CEO of San Diego-based La Jolla, would not disclose the ... Partners (formerly Chase Capital Partners) was the lead investor in this round of financing. La Jolla will have about 35 million ...

Article: DNAPrint(TM) genomics, Inc. Secures Up To $8 Million In Financing ...
PR Newswire;  December 3, 2003 ;     700+ words ... ... commitment from La Jolla Cove Investors ... Board. Athena Capital Partners, Inc. in Tampa ... bank that brought La Jolla Cove Investors ... relationship with La Jolla Cove. This transaction ... 3400 About Athena Capital Partners, Inc. Athena ...

Article: La Jolla Pharmaceutical Company Announces $35.3 ...
PR Newswire;  February 6, 2001 ;     700+ words ... ... 6 /PRNewswire/ -- La Jolla Pharmaceutical Company ... Partners (formerly Chase Capital Partners) for gross proceeds ... corporate purposes. La Jolla Pharmaceutical Company ... this press release about La Jolla Pharmaceutical's plans ...

Article: FDA accepts La Jolla drug application: San ...
San Diego Business Journal;  February 23, 2004 ;     700+ words ... ... based biotechnology firm La Jolla Pharmaceutical Co. said ... investment bank, Roth Capital Partners LLC. in Newport Beach ... a "sell" rating on La Jolla Pharmaceutical's stock ... that the FDA will ask La Jolla Pharmaceutical to run ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives